In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...

Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

The lawsuit, originally filed by the Roofers Local No. 149 Pension Fund in 2023, alleges that Amgen misled shareholders by ...

Seven new clinical trial grants were awarded under the Orphan Product Grants Program during the fiscal year (FY) 2024, ...

A functional point of contact (FPOC) is a dedicated liaison in each functional area responsible for evaluating and ...

The month-long standoff between the US Health Resources and Services Administration (HRSA) and Johnson & Johnson came to an ...

UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...

The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...

Generative AI (GenAI) technology is already transforming everyday regulatory and safety processes, thanks to its ability to ...

AI has the power to conduct these administrative tasks that pharmacists undertake. AI can help pharmacists intervene in a ...